Natural Beauty Bio-Technology Limited
NBBTF
$0.059
-$0.0374-38.80%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.82% | 22.68% | 5.62% | 2.49% | -0.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.82% | 22.68% | 5.62% | 2.49% | -0.54% |
| Cost of Revenue | 55.43% | 33.53% | 11.94% | 4.27% | -3.20% |
| Gross Profit | 29.40% | 15.39% | 1.34% | 1.28% | 1.32% |
| SG&A Expenses | 14.39% | 18.65% | 23.23% | 17.23% | 11.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 134.03% | 109.56% | 84.72% | 39.46% | -8.96% |
| Total Operating Expenses | 31.56% | 26.01% | 20.01% | 12.64% | 5.41% |
| Operating Income | 91.76% | -127.93% | -11,437.85% | -3,715.19% | -884.93% |
| Income Before Tax | -87.99% | -268.64% | -790.23% | -750.74% | -649.53% |
| Income Tax Expenses | -196.27% | -167.00% | -149.64% | -96.05% | -61.77% |
| Earnings from Continuing Operations | -72.84% | -224.75% | -588.76% | -466.86% | -276.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.84% | -224.75% | -588.76% | -466.86% | -276.43% |
| EBIT | 91.76% | -127.93% | -11,437.85% | -3,715.19% | -884.93% |
| EBITDA | 1,996.87% | -66.86% | -200.19% | -154.70% | -107.22% |
| EPS Basic | -62.50% | -211.76% | -570.00% | -462.50% | -300.00% |
| Normalized Basic EPS | 50.00% | -114.29% | -1,100.00% | -800.00% | -500.00% |
| EPS Diluted | -62.50% | -211.76% | -570.00% | -462.50% | -300.00% |
| Normalized Diluted EPS | 50.00% | -114.29% | -1,100.00% | -800.00% | -500.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |